Blood routine test in mild and common 2019 coronavirus (COVID-19) patients
Open Access
- 7 August 2020
- journal article
- research article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 40 (8)
Abstract
The new 2019 coronavirus disease (COVID-19), according to the World Health Organization (WHO), has been characterized as a pandemic. As more is being discovered about this virus, we aim to report findings of the complete blood count (CBC) of COVID-19 patients. This would serve in providing physicians with important knowledge on the changes that can be expected from the CBC of mild and normal COVID-19 patients. A total of 208 mild and common patients were admitted at the Dongnan Hospital located in the city of Xiaogan, Hubei, China. The CBCs of these patients, following a confirmed diagnosis of COVID-19, were retrospectively analyzed and a significant P<0.05 was found after a full statistical analysis was conducted using the Statistical Package for the Social Sciences (IBM SPSS). CBC analysis revealed changes in the levels of red blood cells (RBCs), hemoglobin (HGB), hematocrit (HCT), mean corpuscular volume (MCV), and C-reactive protein (CRP). Clinicians should expect similar findings when dealing with the new COVID-19.Keywords
This publication has 13 references indexed in Scilit:
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Covid-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inactionBMJ, 2020
- COVID‐19 patients' clinical characteristics, discharge rate, and fatality rate of meta‐analysisJournal of Medical Virology, 2020
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, ChinaClinical Infectious Diseases, 2020
- Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2European Journal of Nuclear Medicine and Molecular Imaging, 2020
- Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, ChinaAllergy, 2020
- Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Causes and outcomes of markedly elevated C-reactive protein levels.2017
- Profil étiologique et pronostique des valeurs extrêmes (≥ 500 mg/L) de protéine C-réactive : étude rétrospective de 168 valeurs chez 113 patientsLa Revue de Médecine Interne, 2011